Joseph W. Humphrey

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.

Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.